CuraGen: Calling all genes

Emerging Company Profile

The capability to link genes to specific diseases is a bottleneck that hinders faster drug discovery. Genome sequencing produces catalogs of genetic maps, but it cannot associate genes with disease. Gene inheritance studies that attempt to link genetic regions with disease can take years. And, although gene expression technologies have become very fast, their coverage of expressed genes typically is too incomplete to associate individual genes with disease.

CuraGen has developed a platform that

Read the full 775 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE